ABSTRACT
The compounds in leaf and stem extracts of Astragalus emarginatus Labill.(AEL),a plant species used in traditional Lebanese medicine,were investigated for antioxidant properties.First,the activity of various extracts was assessed using the Trolox equivalent antioxidant capacity,oxygen radical absorption ca-pacity,and 2,2-diphenyl-1-picryl-hydrazy l-hydrate assays.The extract obtained using 30％ethanol showed the greatest activity.The antioxidant compounds in this extract were screened using a hy-phenated high-performance liquid chromatography-2,2-azinobis-(3-ethylbenzothiazoline-6-sulfonate)radical(ABTS+)system before being separated by ultra-high-performance liquid chromatography and identified using high-resolution mass spectrometry and ultra-violet-visible diode array detection.Approximately 40 compounds were identified.Hydroxycinnamates(caffeic,ferulic,and p-coumaric acid derivatives)and flavonoids(quercetin,luteolin,apigenin,and isorhamnetin derivatives)were the two main categories of the identified compounds.The active compounds were identified as caffeic acid de-rivatives and quercetin glycosides.In addition,the catechol moiety was shown to be key to antioxidant activity.This study showed that AEL is a source of natural antioxidants,which may explain its medicinal use.
ABSTRACT
Objective: To test the coalescence effect of two chemotherapy drugs at low effective dose (cisplatin and taxotere) combined with pomegranate juice on A549 cancer cells. Methods: Infrared spectroscopy method is a qualitative test that was performed to ensure the existence of the phytochemicals providing the antioxidant activity through the presence of the hydroxyl group (-OH). The viability of A549 cell line and normal MCs was tested using the neutral red uptake, Clonogenic survival, XTT and Cell migration assays. Results: Our results showed that this combination firstly led to a greater decrease in the viability of cells comparing to those treated with chemotherapy drugs alone, and secondly led to a significant reduction in cell migration. Conclusions: These data suggest a synergistic effect between the pomegranate and cisplatin which makes probably this combination a powerful option for treating lung adenocarcinoma and in parallel minimizing the systemic side effects.